XHSynbio Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B

  • Investors
  • 5

XHSynbio General Information

Description

Developer of pharmaceutical enzymes and chiral chemicals intended for industrial biotechnology and pharmaceutical manufacturing in China. The company's range of products includes enzyme preparations, chiral drug intermediates, nutritional additives, fermentation-derived compounds, specialty reagents and active pharmaceutical ingredients, thereby enabling high-value production through advanced biotechnological processes.

Contact Information

Formerly Known As
Jiaxing Xinhai Biotechnology Co., Ltd.
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, East Gate, Building 1
  • Number 366, Jinpeng Street, Xihu District
  • Hangzhou, Zhejiang 310030
  • China
+86 0571
Primary Industry
Specialty Chemicals
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2nd Floor, East Gate, Building 1
  • Number 366, Jinpeng Street, Xihu District
  • Hangzhou, Zhejiang 310030
  • China
+86 0571

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

XHSynbio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 15-Aug-2025 Completed Generating Revenue
5. Later Stage VC 05-Mar-2025 Completed Generating Revenue
4. Later Stage VC 23-Aug-2024 Completed Generating Revenue
3. Later Stage VC 24-May-2024 Completed Generating Revenue
2. Later Stage VC 10-Mar-2023 Completed Generating Revenue
1. Later Stage VC 06-Aug-2021 Completed Generating Revenue
To view XHSynbio’s complete valuation and funding history, request access »

XHSynbio Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Xi'an Royal-Power Asset Management Venture Capital Minority
Sinochem Capital Corporate Venture Capital Minority
Xihu VC Government Minority
Zhejiang Xianju Pharmaceutical Company Corporation Minority
Goldport Capital Venture Capital Minority
To view XHSynbio’s complete investors history, request access »

XHSynbio FAQs

  • When was XHSynbio founded?

    XHSynbio was founded in 2015.

  • Where is XHSynbio headquartered?

    XHSynbio is headquartered in Hangzhou, China.

  • What industry is XHSynbio in?

    XHSynbio’s primary industry is Specialty Chemicals.

  • Is XHSynbio a private or public company?

    XHSynbio is a Private company.

  • What is XHSynbio’s current revenue?

    The current revenue for XHSynbio is .

  • Who are XHSynbio’s investors?

    Xi'an Royal-Power Asset Management, Sinochem Capital, Xihu VC, Zhejiang Xianju Pharmaceutical Company, and Goldport Capital have invested in XHSynbio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process